Last updated on August 2019

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis


Brief description of study

The primary objective of this study is to evaluate whether obeticholic acid (OCA; INT-747) can lead to histological improvement in fibrosis with no worsening of NASH in adults with compensated cirrhosis due to NASH.

Clinical Study Identifier: NCT03439254

Find a site near you

Start Over

PMG Research of Rocky Mount, LLC

Rocky Mount, NC United States
5.83miles
  Connect »